NHS hospital performance against the four-hour A&E target stood at just 74.96 percent, well under the 95 percent target, for the week ending March 11th, show the most recent data from the Royal College of Emergency Medicine’s Winter Flow Project.
News
Coeliac UK launches new research fund and appeal
Coeliac UK has launched a new research fund and fundraising appeal that aims to raise £5 million to improve understanding and management of coeliac disease and gluten related autoimmune conditions.
Lundbeck snaps up Parkinson’s candidate via Prexton buy
Lundbeck has announced plans to buy Prexton Therapeutics in a deal valued at up to 905 million euros.
US nod for CSL Behring’s Hizentra
US regulators have cleared CSL Behring’s Hizentra for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder affecting the peripheral nerves that can cause permanent nerve damage.
PharmaTimes Clinical Researcher of the Year – The Americas: Book now!
Clinical researchers in the Americas have submitted their essays for this year’s competition and yesterday, the authors and finalists were revealed at a meeting of the executive steering group.
Number of prescriptions rises as net ingredient cost falls
The number of medicines prescribed on the NHS in England increased in 2017 but their net ingredient cost took a downturn, according to data released by NHS Digital.
International Clinical Researcher of the Year 2108 – Venue announced
PharmaTimes International Clinical Researcher of the Year – one of the most important dates in the clinical research calendar – will take place on 17 May at the Millennium Gloucester Hotel in the heart of London’s Kensington.
Amryt in-licenses novel gene therapy platform from UCD
UK biotech Amryt has secured itself access to a novel gene therapy platform that could give rise to a new treatment option for patients with Epidermolysis bullosa (EB), a group of rare inherited skin disorders that cause the skin to become very fragile.
Alexion gears up to file new blood disorder drug
Alexion is gearing up to file its experimental therapy for paroxysmal nocturnal hemoglobinuria (PNH) with regulators on both sides of the Altantic following the success of a late-stage clinical trial.
NICE endorses Keytruda for bladder cancer
MSD’s Keytruda is the first and only immunotherapy to be recommended for NHS use to treat urothelial carcinoma patients, when prior platinum-containing chemotherapy fails.
Researchers call for investigation into rising mortality rates
Researchers are calling for a government investigation into the “substantial increase” in mortality seen in early 2018 in England and Wales.
New guidelines recommend hysteroscopy test for heavy periods
More women in England and Wales are to be offered a test to better determine the causes of heavy menstrual bleeding, on updated guidelines from the National Institute for Health and Care Excellence.
Patients on diabetes scheme shed weight of 15 double cheeseburgers
According to NHS England more than half of patients routinely attending sessions offered as part of its diabetes prevention programme have achieved weight losss equivalent to nearly 15 double cheeseburgers.
Charities link with BenevolentAI to discover new AMD therapies
BenevolentAI has teamed up with Action Against AMD* to find treatments and a potential cure for age-related macular degeneration, the leading cause of blindness in the UK.
Chancellor criticised for lack of action on NHS
Chancellor Philip Hammond boosted growth projections and forecast falling inflation for the UK in his Spring Statement, but health care leaders lamented his lack of action on addressing the NHS crisis.
